Half-year report · Q2
2503.TEDINET S100U68G
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.10T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.13T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥970.2bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥80.9bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥36.9bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥108.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥197.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥57.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥57.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥112.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥32.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥74.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥41.8bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.13T | at 2024-06-30 | Cons. | Assets IFRS |
| Total assets | ¥2.87T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.60T | at 2023-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.55T | at 2024-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.44T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.59T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.33T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.25T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.29T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.13T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.06T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥138.4bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥140.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥88.1bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥108.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥203.2bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥58.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥116.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥226.1bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥56.0bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥21.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥35.9bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥15.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥139.16 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥39.5 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥139.15 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥39.49 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 41.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.5% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.8% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥45.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥34.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥331m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥26.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥513.7bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥512.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥50.3bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥71.1bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥69.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥270.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30.1bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥233.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥232.8bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥132m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥41.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥44.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥13.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥36.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥36.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥24.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥482.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥480.9bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥45.0bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥38.0bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥36.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥4.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥241.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥23.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥199.2bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥199.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥210m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 831
| Item | Context | Value | Unit |
|---|---|---|---|
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYTDDuration | 3244000000 | JPY |
| Interest and dividend income ope cf IFRS | Prior1YTDDuration | -1725000000 | JPY |
| Interest and dividend income ope cf IFRS | CurrentYTDDuration | -6426000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YTDDuration | -17228000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYTDDuration | -20301000000 | JPY |
| Interest expenses ope cf IFRS | Prior1YTDDuration | 2606000000 | JPY |
| Interest expenses ope cf IFRS | CurrentYTDDuration | 3345000000 | JPY |
| Gain on sale of property plant and equipment and intangible assets ope cf IFRS | Prior1YTDDuration | -1177000000 | JPY |
| Gain on sale of property plant and equipment and intangible assets ope cf IFRS | CurrentYTDDuration | -2498000000 | JPY |
| Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRS | Prior1YTDDuration | 488000000 | JPY |
| Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRS | CurrentYTDDuration | 2190000000 | JPY |
| Gain on sales of subsidiaries ope cf IFRS | Prior1YTDDuration | -23000000 | JPY |
| Gain on sales of subsidiaries ope cf IFRS | CurrentYTDDuration | － | JPY |
| Loss on sale of subsidiaries ope cf IFRS | Prior1YTDDuration | 19358000000 | JPY |
| Loss on sale of subsidiaries ope cf IFRS | CurrentYTDDuration | － | JPY |
| Decrease increase in trade receivables ope cf IFRS | Prior1YTDDuration | 60207000000 | JPY |
| Decrease increase in trade receivables ope cf IFRS | CurrentYTDDuration | 24222000000 | JPY |
| Decrease increase in inventories ope cf IFRS | Prior1YTDDuration | -32456000000 | JPY |
| Decrease increase in inventories ope cf IFRS | CurrentYTDDuration | -24236000000 | JPY |
| Increase decrease in trade payables ope cf IFRS | Prior1YTDDuration | -14299000000 | JPY |
| Increase decrease in trade payables ope cf IFRS | CurrentYTDDuration | -553000000 | JPY |
| Increase decrease in liquor taxes payable ope cf IFRS | Prior1YTDDuration | -20032000000 | JPY |
| Increase decrease in liquor taxes payable ope cf IFRS | CurrentYTDDuration | 3062000000 | JPY |
| Increase decrease in deposits received ope cf IFRS | Prior1YTDDuration | -4766000000 | JPY |
| Increase decrease in deposits received ope cf IFRS | CurrentYTDDuration | -4754000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | -40892000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | -17040000000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 57755000000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | 112393000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1YTDDuration | 13650000000 | JPY |
| Interest and dividends received ope cf IFRS | CurrentYTDDuration | 19214000000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -2792000000 | JPY |
| Interest paid ope cf IFRS | CurrentYTDDuration | -2594000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1YTDDuration | -9687000000 | JPY |
| Income taxes paid ope cf IFRS | CurrentYTDDuration | -20302000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YTDDuration | 58926000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYTDDuration | 108711000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | Prior1YTDDuration | -59097000000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf IFRS | CurrentYTDDuration | -68465000000 | JPY |
| Proceeds from sale of property plant and equipment and intangible assets inv cf IFRS | Prior1YTDDuration | 1421000000 | JPY |
| Proceeds from sale of property plant and equipment and intangible assets inv cf IFRS | CurrentYTDDuration | 3763000000 | JPY |
| Purchase of investments inv cf IFRS | Prior1YTDDuration | -654000000 | JPY |
| Purchase of investments inv cf IFRS | CurrentYTDDuration | -1419000000 | JPY |
| Proceeds from sales of investments inv cf IFRS | Prior1YTDDuration | 6393000000 | JPY |
| Proceeds from sales of investments inv cf IFRS | CurrentYTDDuration | 1585000000 | JPY |
| Purchase of shares of subsidiaries inv cf IFRS | Prior1YTDDuration | － | JPY |
| Purchase of shares of subsidiaries inv cf IFRS | CurrentYTDDuration | -48196000000 | JPY |
| Payment for sale of shares of subsidiary due to change in scope of consolidation inv cf IFRS | Prior1YTDDuration | -5006000000 | JPY |
| Payment for sale of shares of subsidiary due to change in scope of consolidation inv cf IFRS | CurrentYTDDuration | － | JPY |
| Proceeds from sale of shares of subsidiaries inv cf IFRS | Prior1YTDDuration | 245000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |